Sijia Yin

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

TREM2 signaling in Parkinson's disease: Regulation of microglial function and α-synuclein pathology.

TREM2 signaling in Parkinson's disease: Regulation of microglial function and α-synuclein pathology.

Journal: International immunopharmacology

Published: July 31, 2024

Astrocyte-neuron communication through the complement C3-C3aR pathway in Parkinson's disease.

Astrocyte-neuron communication through the complement C3-C3aR pathway in Parkinson's disease.

Journal: Brain, behavior, and immunity

Published: June 17, 2024

Mitochondria-lysosome-extracellular vesicles axis and nanotheranostics in neurodegenerative diseases.

Mitochondria-lysosome-extracellular vesicles axis and nanotheranostics in neurodegenerative diseases.

Journal: Experimental neurology

Published: December 21, 2023

Circadian regulation of microglia function: Potential targets for treatment of Parkinson's Disease.

Circadian regulation of microglia function: Potential targets for treatment of Parkinson's Disease.

Journal: Ageing research reviews

Published: July 17, 2023

Plasma exosomes impair microglial degradation of α-synuclein through V-ATPase subunit V1G1.

Plasma exosomes impair microglial degradation of α-synuclein through V-ATPase subunit V1G1.

Journal: CNS neuroscience & therapeutics

Published: May 07, 2023

Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's disease.

Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's disease.

Journal: Neurobiology of disease

Published: May 03, 2023

Efficacy and safety of 3-n-butylphthalide for the treatment of cognitive impairment: A systematic review and meta-analysis.

Efficacy and safety of 3-n-butylphthalide for the treatment of cognitive impairment: A systematic review and meta-analysis.

Journal: CNS neuroscience & therapeutics

Published: May 16, 2022

The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.

The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.

Journal: Journal of neuroinflammation

Published: November 20, 2021

Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A): Could It Be a Promising Biomarker and Therapeutic Target in Parkinson's Disease?

Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A): Could It Be a Promising Biomarker and Therapeutic Target in Parkinson's Disease?

Journal: Molecular neurobiology

Published: June 03, 2021

Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.

Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.

Journal: Frontiers in immunology

Published: June 03, 2021

Calcitriol Alleviates MPP+- and MPTP-Induced Parthanatos Through the VDR/PARP1 Pathway in the Model of Parkinson's Disease.

Calcitriol Alleviates MPP+- and MPTP-Induced Parthanatos Through the VDR/PARP1 Pathway in the Model of Parkinson's Disease.

Journal: Frontiers in aging neuroscience

Published: January 22, 2021

Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2.

Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2.

Journal: Brain : a journal of neurology

Published: July 20, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026